Genomic Vision SA
PAR:GV
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GV's stock price target?
Not Available
GV doesn't have any price targets made by Wall Street professionals.
What is Genomic Vision SA's Revenue forecast?
Projected CAGR
19%
For the last 8 years the
compound annual growth rate for
Genomic Vision SA's revenue is
-14%.
The projected
CAGR
for the next 4 years is
19%.